PIM1 is a constitutively active serine/threonine kinase regulated by cytokines, growth factors and hormones. It has been implicated in the control of cell cycle progression and apoptosis and its overexpression has been associated with various kinds of lymphoid and hematopoietic malignancies. The activity of PIM1 is dependent on the phosphorylation of several targets involved in transcription, cell cycle and apoptosis. We have recently observed that PIM1 interacts with ribosomal protein (RP)S19 and cosediments with ribosomes. Defects in ribosome synthesis (ribosomal stress) have been shown to activate a p53-dependent growth arrest response. To investigate if PIM1 could have a role in the response to ribosomal stress, we induced ribosome synthesis alterations in TF-1 and K562 erythroid cell lines. We found that RP deficiency, induced by RNA interference or treatment with inhibitor of nucleolar functions, causes a drastic destabilization of PIM1. The lower level of PIM1 induces an increase in the cell cycle inhibitor p27
Introduction
PIM1 oncogene is highly expressed not only in hematopoietic cells, but also in other tissues, such as epithelial cells, prostate and hippocampus (Bachmann and Moroy, 2005) . It is regulated by a variety of growth factors and cytokines at the transcriptional, posttranscriptional, translational and post-translational levels in response to stress conditions, such as ischemias and cellular hypoxia (Wang et al., 2001; Bachmann and Moroy, 2005; Shah et al., 2008) . Oncogenic properties have been observed in animal models where PIM1 enhances the development of lymphoma and leukemia (Selten et al., 1985; van Lohuizen et al., 1989) . In these experimental systems, PIM1 cooperates with MYC in lymphomagenesis, possibly by suppressing MYCinduced apoptosis. More recently, it has been shown that PIM1 colocalizes with MYC at sites of active transcription; thus, contributing to the expression of part of the MYC-regulated genes (Zippo et al., 2007) . Animals deficient in PIM1 are viable and show only a minor defect in hematopoiesis (Laird et al., 1993) . This suggests that PIM1 contributes to hematopoietic cell growth and survival, although its role is probably secondary to other signaling pathways. According to this, combined deficiency of PIM1 and AKT1 caused a severe impairment in hematopoietic cell growth, survival and proliferation (Hammerman et al., 2005) . Several regulators of cell cycle progression and apoptosis have been identified as PIM1 targets, implicating it in the control of cell cycle and cell survival (Wang et al., 2001; Bachmann and Moroy, 2005) . Among them, the cyclindependent kinase (CDK) inhibitor p27 Kip1 , shown to be phosphorylated and downregulated by PIM1 (Morishita et al., 2008) , has been proposed as a specific controller of hematopoietic cell proliferation (Steinman, 2002; Soeiro et al., 2006) . Deregulation of the expression of PIM1 kinase has been associated with the development of human malignancies, including lymphomas, leukemias, prostate cancer, squamous cell carcinoma, gastric carcinoma and colorectal carcinoma (reviewed by Shah et al., 2008) .
PIM1 kinase has been recently identified as an interactor of ribosomal protein (RP)S19 (Chiocchetti et al., 2005) . The interaction, found in a two-hybrid screen, was confirmed by co-immunoprecipitation experiments. Moreover, PIM1 was shown to cosediment with ribosomal particles in sucrose gradient fractionation analysis. To investigate the physiological function of the PIM1-ribosome interaction, we decided to test if alteration of ribosome synthesis could affect PIM1 expression. Ribosome synthesis is a complex process taking place sequentially in the nucleolus, in the nucleoplasm and in the cytoplasm. It involves four ribosomal RNA molecules, about 80 RPs and nearly 200 non-ribosomal factors that are required for the synthesis, maturation and export of the two ribosomal subunits (Fatica and Tollervey, 2002) . A number of reports suggest that perturbations of ribosome biogenesis, owing to a variety of causes (ribosomal stress), can activate a specific checkpoint and block cell proliferation mostly through a p53-dependent mechanism (Pestov et al., 2001; Rubbi and Milner, 2003; Anderson et al., 2007; Panic et al., 2007; Danilova et al., 2008; McGowan et al., 2008; Fumagalli et al., 2009 ). This occurs, for example, in the case of conditional deletion of RPS6 (Volarevic et al., 2000; Sulic et al., 2005) or in response to drugs that disrupt nucleolar structures (Rubbi and Milner, 2003) . Alteration of ribosome synthesis has also been implicated in some pathologies that are associated to mutations in ribosomal components, for instance, Diamond-Blackfan anemia (DBA), or in molecules involved in ribosome maturation (reviewed by Liu and Ellis, 2006 and Caldarola et al., 2009) .
To address if PIM1 could be involved in the response to ribosomal stress, we used TF-1 and K562 erythroidcultured cells. We found that RP deficiency and other kinds of ribosomal stress cause a decrease of PIM1 level. As a consequence, the PIM1 target, p27 Kip1 , increases; thus, blocking cell cycle progression.
Results

Interaction of PIM1 with the ribosome
We have shown that PIM1 interacts with the ribosome in human embryonic kidney cells (Chiocchetti et al., 2005) . To verify that this occurs also in hematopoietic cells, cytoplasmic extracts from both TF-1 and K562 cells were separated by ultracentrifugation into two fractions: (1) P, pellet, which includes polysomes and ribosomal subunits; and (2) S, super, which includes free cytosolic proteins. Western blot analysis of the two fractions ( Figure 1a) showed that most of the cytoplasmic PIM1 is observed in the polysomal pellet in both cell lines. Importantly, treatment of K562 cells with the crosslink-inducing agent dithiobis(succinimidyl propionate) (DSP) can stabilize PIM1-ribosome interaction. In fact, DSP treatment of the cells prevents dissociation of PIM1 induced by high salt concentration in cell extract (Figure 1b) , indicating that the PIM1-ribosome interaction occurs in the cell under physiological conditions. Further separation of TF-1 cytoplasmic extracts on sucrose gradients showed that PIM1 is associated both with polysomes and with free 40S ribosomal subunit (Figure 1c) . Quantification of the percentage of PIM1 in the different fractions shows that the vast majority is associated with active polysomes and 40S ribosomal subunit (Figure 1c) . Interestingly, the ratio between PIM1 and RPS19 appears higher in polysomes (fraction 1) compared with free 40S (fraction 6). This indicates that PIM1 may interact preferentially with active ribosomes.
Effect of RPS19 deficiency
To study the effect of alteration of ribosome synthesis on PIM1 expression, we used two modified cell lines, TF-1C and K562C, both infected with a lentiviral vector inducible for the expression of small interfering RNA specific for RPS19 mRNA (Miyake et al., 2005) . The two parental cell lines differ in p53 expression: TF-1 expresses a wild-type p53 (Urashima et al., 1998) , whereas K562 does not show detectable levels of p53. As a control for p53 activity in TF-1C, we treated the cells with the genotoxic agent bleomycin, observing p53 increase by western blot and p21
Waf1 activation by realtime reverse transcription-polymerase chain reaction (RT-PCR) and western blot (Supplementary Figures S1A and S1B) Cytoplasmic extracts from TF-1 and K562 cells were separated by ultracentrifugation in a pellet (P), including ribosomes and ribosomal subunits and a supernatant (S), containing free cytoplasmic proteins. The two fractions were analyzed by western blot with primary antibodies against PIM1 (PIM), RPS19 (S19) and b-actin (ACT). Loading ratio between P and S was 10:1. (b) An aliquot of K562 cells was treated with the crosslinking-inducing agent (dithiobis(succinimidyl propionate (DSP)). Cytoplasmic extracts of treated and control cells were separated as in (a), in the presence of high-salt concentration. Blots were decorated as in (a), including antibodies against eukaryotic initiation factor 4E. Loading ratio between P and S was 3:1. (c) Cytoplasmic extract from TF-1 cells was separated by ultracentrifugation on a linear sucrose gradient. Fractions were collected while monitoring absorbance at 260 nm. The pellet, containing polysomes, was pooled to the first fraction. Fraction aliquots were precipitated by trichloroacetic acid and analyzed by western blot with primary antibodies against PIM1 (PIM), RPS19 (S19), RPL7a (L7a), b-tubulin (TUB) and AKT (AKT). The upper panel shows the absorbance profile with the position of ribosomal subunits and monomer 80S indicated by arrows. Lanes corresponding to fractions 9, 10, 11 contain one-half, one-third, one-sixth of the other fractions, respectively. Quantifications of the percentage of PIM1 and the ratio between PIM1 and RPS19 in the different fractions is reported on the right of the panel as a column plot.
observed that RPS19 deficiency in K562C cells caused a reduction of other RPs from the small subunit, but not from the large one (Supplementary Figure S2A) . This alteration is also visible as a decrease of the 40S peak on the absorbance profile (polysomal profile) of cytoplasmic extract of dox-induced K562C cells (Supplementary Figure S2B) .
Cell counting and fluorescence-activated cell sorting (FACS) analysis showed that the induction of RPS19 deficiency causes an evident reduction of cell proliferation and an accumulation of cells in the G0/G1 phase of the cell cycle (Figures 2b and c) . It is important to note that alteration of cell cycle and proliferation can also be observed in the p53-null K562C cells, suggesting that a (c) were analyzed by western blot with primary antibody against RPS19 (S19), PIM1 (PIM), p27
Kip1 (p27), p53 (p53) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). An example of western blot is shown on the left. Quantification of at least three blots from two independent experiments is reported on the right as a column plot of the mean ± s.e.m. of the values normalized for GAPDH and considering untreated sample as 1. (e) K562C cells were treated for 4 or 6 days (4d, 6d) with dox. Total protein extracts were separated on SDS-PAGE and transferred onto nitrocellulose membrane. Blots were decorated with primary antibodies against RPS19 (S19), PIM1 (PIM), total p27
Kip1 (p27), threonine157-phosphorylated p27 (pp27) and b-actin (ACT). Quantification of the ratio between phospho-p27
Kip1 and p27 Kip1 is reported on the right as a column plot considering untreated sample as 1.
Ribosomal stress affects PIM1 level V Iadevaia et al p53-independent mechanism is activated in these cells. Western analysis of both TF-1C and K562C cells showed that, during induction, in parallel to RPS19 decrease, there is a comparable reduction of PIM1 level, whereas the level of the CDK inhibitor p27 Kip1 increases (Figure 2d ). In addition, in TF-1 cells there is an increase in the level of p53. To address the relationship between PIM1 decrease and p27 Kip1 increase, we analyzed the phosphorylation status of threonine157 that is one of the PIM1 target sites on p27
Kip1 (Morishita et al., 2008) during induction of K562C cells. As shown in Figure 2e , PIM1 reduction correlates with the decrease of threonine157 phosphorylation. As phosphorylation on this site (together with threonine198) has been shown to inhibit p27
Kip1 activity and induce its degradation (Larrea et al., 2009) , our results indicate that the decline of PIM1 level could cause stabilization and activation of p27 Kip1 .
Alteration of PIM1 turnover
To investigate the change of PIM1 and p27
Kip1 levels observed in TF-1C and K562C cells following dox treatment, we analyzed mRNA levels and translation efficiency. Northern analysis of K562C cells did not show any difference in PIM1 mRNA level during RPS19 knockdown ( Figure 3a) ; similarly, polysomal association of PIM1 messenger did not decrease during dox treatment (Figure 3b ), ruling out regulation at the level of transcription, mRNA stability and translation. We also analyzed p27
Kip1 mRNA level by real-time RT-PCR, observing no significant alteration in RPS19-deficient K562C and TF-1C cells (Figure 3c ). To address the possible variation of protein stability, we treated K562C cells with the translation inhibitor cycloheximide and monitored the decrease of PIM1 levels in control and induced cells. The decay of PIM1 level is very rapid (Figure 3d ). However, the induction of RPS19 interference causes a further destabilization of the protein, which after 15 min is almost undetectable. To further show that the decrease of PIM1 level, observed in RPS19-deficient cells, was caused by post-translational destabilization, we treated both control and induced K562C and TF-1C cells with an inhibitor of the proteasome (MG132), which is the main mediator of PIM1 degradation (Shay et al., 2005) . Consistent with the previous experiment, inhibition of the proteasome in RPS19-deficient cells causes the recovery of PIM1 to Figure 3A) . This suggests that RPS19 deficiency stimulates the proteasome activity on PIM1. In the same experiment, we have analyzed the level of p27 Kip1 . In this case, we observed that proteasome inhibition increases p27
Kip1 level in control cells, but not in induced cells. Therefore, the increase observed during RPS19 deficiency is owing to a lower proteasome activity on p27 Kip1 , possibly as a consequence of PIM1 reduction (Figure 3e ). The conclusion is that RPS19 reduction causes an increase in proteasomemediated degradation of PIM1 and an inhibition of p27 Kip1 degradation.
Other conditions of ribosomal stress Next, we asked if the deficiency of other RPs would cause the same effect. To answer this question, we transfected TF-1 cells with siRNA specific for RPS6 and RPL7a. The analysis of protein levels by western blot showed that, in both cases, the decrease of the RP causes a reduction of PIM1 level (Figure 4a ). This result suggests that the diminution of PIM1 is not dependent on the deficiency of a specific RP, but is rather owing to the decrease of active ribosomes caused by RP insufficiency. As a further example of alteration of ribosome synthesis, we used inhibition of RNA polymerase I activity. It has been shown that treatments that alter nucleolar function, for instance, inhibition of ribosomal RNA synthesis, induce a p53-dependent stress response (Rubbi and Milner, 2003; Mayer and Grummt, 2005) . We decided to test if treatment with agents that interfere with ribosomal RNA production would affect PIM1 level similarly to RP deficiency. K562 cells were treated for 16 h with actinomycin D, camptothecin and cisplatinum, all known to affect ribosomal RNA synthesis at different steps. As a control, we treated the cells with the cell cycle inhibitors nocodazole and hydroxyurea, which do not affect nucleolar function. Western analysis showed that treatment with all three inhibitors of nucleolar function causes a decrease of PIM1 level, whereas nocodazole and hydroxyurea do not affect it (Figure 4b ). Actinomycin D effect on PIM1 level was also observed in TF-1C cells even after 3 h of treatment (Supplementary Figure S3B) . To investigate if the decrease of PIM1 level induced by RNA polymerase I inhibitors was caused by proteasome-mediated degradation, we used the proteasome inhibitor MG132. K562C cells were incubated for 16 h with actinomycin D and then treated for 2 h with MG132. Western analysis (Figure 4c) showed that proteasome inhibition induces a recovery of PIM1 levels. This indicates that actinomycin D, similarly to RPS19 deficiency, induces PIM1 destabilization. Analogous effect of MG132 on PIM1 level was observed in TF-1C cells (Supplementary Figure S3C) .
Further correlation between defective ribosome synthesis and reduction of PIM1 level was obtained by analyzing lymphoblastoid cell lines derived from two DBA patients. In both cases, the genetic alteration responsible for the disease has not yet been identified. However, on the basis of the available data on the disease, we can assume that these cells have a ribosomal defect. Western analysis showed that extracts from DBA cell lines had a lower PIM1 level compared with controls Ribosomal stress affects PIM1 level V Iadevaia et al (Figure 4d ), confirming the link between ribosome functionality and the kinase amount.
PIM1 overexpression attenuates ribosomal stress
At this point, we hypothesized that the growth arrest induced by ribosomal stress, observed in our experimental systems, could be owing to the destabilization of PIM1. This would affect cell growth and proliferation through the stabilization of the PIM1 target p27
Kip1
. To verify our hypothesis and establish a causal relationship between PIM1 decrease and the alterations observed in RPS19-deficient cells, we carried out a rescue experiment by transiently transfecting PIM1-expressing plasmids into TF-1C and K562C cells after induction of RPS19 interference. FACS analysis and growth curves showed that transient expression of PIM1 causes a recovery of cell cycle progression and proliferation both in TF-1C and in K562 cells (Figures 5a and b) . In addition, western analysis showed that restoring the PIM1 level during RPS19 interference causes an evident reduction of p27
Kip1 levels in TF-1C cells (Figure 5c ). The effect of PIM1 transfection on p27
Kip1 level is less marked in K562C cells. This suggests that, in this cell type, the cell cycle effects are not mediated exclusively by p27 Kip1 . Interestingly, the level of p53, present only in TF-1C cells, is also affected by PIM1 transfection.
To further verify our working model, we decided to knock down the expression of p27
Kip1 by RNA interference (RNAi) in RPS19-deficient TF-1C and K562C cells to obtain a recovery of the cell cycle progression. For this purpose, TF-1C and K562C cells were induced with dox for 4 or 6 days. Part of the cells was transfected with an unrelated siRNA (siC) or with a p27 Kip1 -specific siRNA either at the beginning or after 2 days of induction. Western analysis of cell extracts indicated that the transfection of p27 Kip1 -specific siRNA caused a clear reduction of protein level (Figure 6a ). FACS analysis of both TF-1C and K562C cells (Figure 6b) showed that the increase in the percentage of G0/G1 cells caused by RPS19 deficiency is attenuated by the knockdown of p27 Kip1 , confirming the hypothesis that PIM1 affects cell cycle through this CDK inhibitor.
Discussion
It is now well documented that ribosomal stress, defined as an alteration of ribosome synthesis, can induce the activation of the tumor suppressor p53 blocking cell proliferation and activating apoptosis (Pestov et al., 2001; Sulic et al., 2005; Anderson et al., 2007; Panic et al., 2007; Danilova et al., 2008; McGowan et al., 2008; Fumagalli et al., 2009) . Here, we report the analysis of the effect of RPS19 deficiency on the metabolism of two erythroid cell lines. Our data suggest the existence of p53-independent response to ribosomal stress. In fact, we found that both in the presence (TF-1) and in the absence (K562) of p53, the insufficiency of RPS19 causes cell cycle arrest and a block in cell proliferation.
Following our previous finding of an interaction between PIM1 and the ribosome, we addressed the possibility of a role of this kinase in response to the ribosomal alteration. PIM1 is able to phosphorylate several targets involved in cell cycle progression and apoptosis, and it has been implicated in signaling pathways relevant for cell survival (Bachmann and Moroy, 2005) . We observed that RP deficiency induced by RNAi or treatment with inhibitors of nucleolar functions cause destabilization of PIM1. The increase in degradation is mediated by the proteasome and could be owing to reduced availability of ribosomes for binding with a consequent rapid degradation of free (unbound) PIM1 (Figure 6c ). In fact, we observed a decrease of 40S subunit and possibly of active ribosomes during the induction of RPS19 deficiency. However, it could be that ribosomal stress activates molecules involved in PIM1 degradation, such as PP2A (Losman et al., 2003) . In any case, we think that PIM1 decrease triggers at least some of the effects of ribosomal stress. In fact, both in TF-1C and in K562C cells, the lower level of PIM1 correlates with (1) an increase in the CDK inhibitor p27
Kip1 that is hypophosphorylated on threonine157 (at least in K562C cells), (2) proliferation decline and (3) inhibition of cell cycle progression. Importantly, restoring PIM1 level by transfection, during the induction of RPS19 deficiency, significantly attenuates all these effects: p27
Kip1 resumes a low level, and cell proliferation and cell cycle progression are recovered. Moreover, the knockdown of p27
Kip1 in RPS19-deficient cells causes, at least partially, a recovery of cell cycle progression. It should be noted that the recovery of cell growth occurs without affecting RPS19 level. This indicates that the proliferation block was not owing to intrinsic insufficiency of the translation machinery, but to a specific checkpoint mechanism. The working model we would like to propose is that PIM1 can act as a sensor for ribosomal stress. In fact, using RPS19 as a docking site, PIM1 interacts with active ribosomes and is stabilized by the binding. A decrease of available ribosomes, owing to deficiency of an RP or ribosomal RNA, would cause degradation of unbound PIM1. In addition, the well-documented function of PIM1 as a regulator of cell cycle and cell growth fits well with the role of transducing the stress signal to various key cellular components. Among the PIM1 targets possibly involved in the response to ribosomal stress, we tested p27
Kip1 because: (1) it is rapidly destabilized by PIM1 phosphorylation (Morishita et al., 2008) and (2) it is a key controller of cell cycle progression of hematopoietic cells (Steinman, 2002) . We found that p27
Kip1 level increases in response to alteration of ribosome synthesis in a PIM1-dependent way, both in the absence (K562C) and in the presence (TF-1C) of p53. Furthermore, the decrease of p27 Kip1 , caused by RNAi, partially restores cell cycle. However, the role of p27
Kip1 in mediating the effect of RPS19 deficiency appears less evident in K562C cells. Therefore, it could be that in these cells, and possibly in TF-1C cells as well, other PIM1 targets, such as p21 Waf , CDC25A, CDC25C, and so on, might have a role in the response to ribosomal stress.
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It is important to underline that this is the first characterization of a stable interaction of a kinase with the mammalian ribosome. Moreover, PIM1 has been involved in the development of human malignancies. It could be that the mechanism we have described is an integral part of the complex relationship between ribosome and cancer that has been addressed by several studies (reviewed by Ruggero and Pandolfi, 2003) . In any case, our data suggest an entirely new perspective in the analysis of the PIM1-dependent oncogenesis. Finally, the relationship between PIM1 and the p53-dependent response to ribosomal stress remains to be elucidated and will be an important subject for future investigation.
Materials and methods
Cell culture and transient transfection Human erythroleukemic TF-1 and K562 cells were maintained in RPMI media supplemented with 10% fetal bovine serum, and antibiotics (100 IU/ml penicillin and 100 mg/ml streptomycin). TF-1 medium was also supplemented with 5 ng/ml granulocyte-macrophage colony-stimulating factor. Human lymphoblastoid cells lines were established by Epstein-Barr virus immortalization of patients' blood lymphocytes. Cells were maintained in suspension in RPMI 1640 medium supplemented with 10% fetal bovine serum, 50 mg/ml penicillin and 50 mg/ml streptomycin.
TF-1C and K562C cells, expressing inducible siRNA targeting RPS19 mRNA, were prepared in Karlsson's laboratory (Miyake et al., 2005) . Cells (5 Â 10 6 ) were transiently transfected using 15 mg of plasmid DNA and 30 ml of JetPei transfection reagent (Polyplus transfection), or with 100-200 nM siRNA and 10 ml of Interferin transfection reagent (Polyplus transfection) according to the manufacturer's protocol. After 24 h, the cells were harvested and analyzed by western blot, or in the case of RNAi, after 48 h they were retransfected and then harvested and analyzed by western blot. Plasmids encoding full-length human PIM1 and RPS19 have been described previously (Chiocchetti et al., 2005) . The RNAi target sequences were as follows: sense, 5 0 -GTAAGAAAGC CCTTAAATA-3 0 for human RPS6, sense, 5 0 -CACCACCTT GGTGGAGAACAA-3 0 for human RPL7a and sense, 5 0 -GCA GGAAUAAGGAAGCGACCUGCAA-3 0 for human p27
Kip1
. As a control, siRNA targeting the unrelated protein ZNF9 (sense, 5
0 -GACAAGUGAAGUCAACUGU-3 0 ) was used. Kip1 destabilizing it; during ribosomal stress, the decrease of ribosomes renders PIM1 available for degradation by the proteasome. As a consequence, p27
Kip1 is stabilized and the cell cycle is arrested.
Ribosomal stress affects PIM1 level V Iadevaia et al
RNA analysis
For polysomal RNA analysis, cells (1-2 Â 10 6 ) that had been washed once with phosphate-buffered saline buffer (150 mM NaCl, 2.7 mM KCl, 8 mM NaH 2 PO 4 and 1.4 mM K 2 PO 4 ) were lysed with 300 ml of lysis buffer (10 mM NaCl, 10 mM MgCl 2 , 10 mM Tris-HCl (pH 7.5), 1% Triton X-100, 1% sodium deoxycholate, 36 U/ml RNase inhibitor (Promega, Milan, Italy), 1 mM dithiothreitol) and transferred into a microcentrifuge tube. After 5 min of incubation in ice with occasional vortexing, the lysate was centrifuged for 8 min at 10 000 r.p.m. at 4 1C. The supernatant was frozen in liquid nitrogen and stored at À70 1C to be analyzed later, or immediately layered in a 15-50% (w/v) sucrose gradient containing 30 mM Tris-HCl (pH 7.5), 100 mM NaCl and 10 mM MgCl 2 , and centrifuged in a Beckman SW41 rotor for 110 min at 37 000 r.p.m. Fractions were collected while monitoring the optical density at 254 nm and total RNA was extracted from each fraction by the proteinase K method. For northern analysis, RNA was fractionated on formaldehyde-agarose gels and transferred onto GeneScreen Plus membrane (Perkin-Elmer Life Sciences, Milan, Italy). Northern blotting was performed essentially as recommended by the manufacturer. Radioactive probes were prepared by the random primer technique using DNA fragments isolated from plasmids containing PCRamplified cDNA sequences. Primers for amplification were designed according to sequences present in the NCBI Data Bank.
For real-time RT-PCR, total RNA was extracted from cells using Eurogold Trifast (Euroclone, Milan, Italy), according to the manufacturer's protocol. RNA (2.5 mg) was treated with DNAse I (Promega), then reverse transcribed into singlestrand cDNA, using Moloney murine leukemia virus reverse transcriptase (Promega) and random primers (Invitrogen, Milan, Italy). cDNA was diluted at a concentration of 80 ng/ ml in nuclease-free water and stored in aliquots at À80 1C until used. Real-time PCR was performed with the LightCycler (Roche Diagnostics, Milan, Italy) using SYBR green detection (Kapa SYBR Fast qPCR kit; Kapa Biosystems, Woburn, MA, USA), the cDNA as the template and the primer mix of interest as follows: glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_002046.3: sense primer, 5 0 -ACCAGGGCTG CTTTTAACTCTGGT-3 0 ; antisense primer, 5 0 -GCAAATTT CCATGGCACCGTCAAGG-3 0 ; p27 Kip1 NM_004064: sense primer, 5 0 -ACGTGAGAGTGTCTAACGG-3 0 ; antisense primer, 5 0 -AGTGCTTCTCCAAGTCCC-3 0 ; p21 Waf1 NM_000389: sense primer, 5 0 -CGGCAGACCAGCATGACAGATTT-3 0 ; antisense primer, 5 0 -TCAAAGGCCCGCTCTACATCTT-3 0 . The amount of mRNA transcripts encoding these genes was determined using the expression 2 ÀDDCt , considering the threshold cycle (Ct) of the sample relative to the internal reference GAPDH (DCt) and to untreated cells (DDCt).
Western blotting
Proteins were separated on 12% sodium dodecyl sulfatepolyacrylamide gel, and transferred onto nitrocellulose Protran membrane (Schleicher and Schuell, Milan, Italy) , and incubated with the following primary antibodies and antisera: mouse monoclonal antibody specific for RPS19 (Orru et al., 2007) , mouse monoclonal anti-GAPDH (Chemicon, Milan, Italy), rabbit polyclonal anti-RPS6 (Cell Signaling, Boston, MA, USA), rabbit polyclonal anti-b-actin (Sigma, Milan, Italy), mouse monoclonal anti-PIM1 (Santa Cruz, Heidelberg, Germany), mouse monoclonal anti-p53 (Santa Cruz), rabbit polyclonal anti-L7a (kindly provided by Giulia Russo, Naples, Italy), rabbit polyclonal anti-AKT (Santa Cruz), mouse monoclonal anti-p27
Kip1 (BD, Milan, Italy), rabbit polyclonal anti-phospho-p27
Kip1 (threonine157; R&D Systems (Minneapolis, MN, USA), kindly provided by Giuseppe Viglietto, Catanzaro, Italy), rabbit polyclonal anti-eIF4E (Cell Signaling) and rabbit polyclonal anti-b-tubulin (Santa Cruz). Primary antibodies were revealed using horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse Ab (Jackson Immunoresearch, Suffolk, UK) and the ECL chemiluminescence detection system (Pierce, Rockford, IL, USA). Quantification analyses were performed by LAS3000 Image System (Fuji, Milan, Italy) and ImageQuant software (GE Healthcare, Milan, Italy).
Ribosome isolation and crosslinking assay TF-1 or K652 cells were pelleted and resuspended in lysis buffer (10 mM NaCl, 10 mM MgCl 2 , 10mM Tris-HCl (pH 7.5), 0.5% NP-40, aprotinin 1 mg/ml, leupeptin 1 mg/ml, pepstatinA 1 mg/ml, phenylmethylsulfonyl fluoride 100 mg/ml). After incubation in ice for 1 min, the extract was centrifuged for 1 min in a microcentrifuge at a maximum speed at 4 1C and the supernatant (cytoplasmic extract) was frozen in liquid nitrogen. To isolate ribosomes and ribosomal subunits, the cytoplasmic extracts were spun at 100 000 g for 2 h on 15% sucrose cushion. After centrifugation, the pellet (which includes polysomes and ribosomal subunits) was resuspended in Loading Buffer (63 mM Tris-HCl (pH 6.8), 5% glycerol, 1% SDS, 2.5% bromophenol-blue), whereas the supernatant was precipitated with 10% trichloroacetic acid and resuspended in Loading Buffer. To separate polysomes and ribosomal subunits, cytoplasmic extracts were loaded onto a 10-30% linear sucrose gradient containing 30 mM Tris-HCl (pH 7.5), 100 mM NaCl and 10 mM MgCl 2 . Gradients were centrifuged in a Beckman SW 41 rotor for 5 h at 37 000 r.p.m. and then collected in 11 fractions while monitoring the absorbance at 260 nm. The pellet and trichloroacetic acid-precipitated fractions were washed with acetone, dried, resuspended in Loading Buffer and analyzed by western blot. For crosslinking experiments, DSP was prepared as a stock solution of 50 mg/ ml in dimethyl sulfoxide and added to the cell culture medium to a final concentration of 1 mg/ml (2.5 mM). Cells were then incubated at 37 1C, and after 10 min, the DSP was quenched by adding Tris-HCl (pH 8.0) to a final concentration of 100 mM. After 10 min incubation at room temperature, the cells were lysed and the cytoplasmic extracts were incubated with highsalt buffer (0.5 M KCl) for 30 min in ice. The extracts were then separated into a ribosomal pellet and 'free' cytosolic proteins as described above.
Proliferation assay and flow cytometry analysis K562 and TF-1 cells (uninduced or induced with 2 mg/ml dox) were seeded in triplicate. Cell aliquots were harvested and counted with a Nebauer chamber after Trypan blue staining. Cultures were diluted to maintain approximately constant cell concentration (5-10 Â 10 5 cells per ml). For flow cytometry, cells were washed in phosphatebuffered saline, fixed for 30 min at 4 1C with methanol:acetone (4:1), treated for 20 min with RNAse A (100 mg/ml) and stained with propidium iodide (1 mg/ml) for 20 min at room temperature. Then, cells were analyzed by a FACSCalibur instrument (Becton Dickinson, Milan, Italy) and the percentage of cells in the different cell cycle phases was evaluated with CellQuest software.
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